… Extracorporeal photopheresis (ECP) has objective activity in the treatment of both acute
and chronic corticosteroid-refractory GvHD patients, has an excellent safety profile and is …

… Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric …
use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-…

… long-term morbidity in survivors of allogeneic stem cell transplantation. Extracorporeal
photopheresis (… in patients with refractory acute and chronic GVHD. Clinical responses have been …

… photopheresis (ECP) in chronic graft-versushost disease (GVHD). Eleven patients with
chronic … Our results indicate that ECP can benefit patients with cutaneous and mucosal chronic …

… We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated
with extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

… Our results in chronic GVHD support previous reports of objective … extracorporeal
photopheresis. All of these results indicate activity of extracorporeal photopheresis in acute and …

… trial, we found that a 12-week course of extracorporeal photopheresis (ECP) plus standard
… with corticosteroid-refractory/intolerant/dependent chronic graft-versus-host disease (GVHD). …

… Extracorporeal photopheresis (ECP) has been used for over 30 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic graft‐versus‐…

… Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy,
involves ex vivo exposure of mononuclear cells obtained by apheresis to a photosensitizing …

… phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host
disease, pp 2593-4, Copyright © 2008 The American Society of Hematology. …